99-3775. Current Issues in Human Subject Protection; Public Meeting  

  • [Federal Register Volume 64, Number 31 (Wednesday, February 17, 1999)]
    [Notices]
    [Page 7896]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-3775]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Current Issues in Human Subject Protection; Public Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice of meeting.
    
    -----------------------------------------------------------------------
    
         The Food and Drug Administration (FDA) is announcing a national 
    conference regarding issues in human research subject protection. 
    Current regulatory issues, historical perspectives and future 
    directions will be presented. Participants will have the opportunity to 
    interact with senior Federal personnel and learn about developments in 
    policy and regulations which affect the Institutional Review Board 
    (IRB) system and the conduct of research involving human subjects.
    
    Date and Time: The meeting will be held on March 5, 1999, 8:30 a.m. to 
    4:45 p.m.
    
    Location: The meeting will be held at Natcher Auditorium, National 
    Institutes of Health Campus, Bldg. 45, 9000 Rockville Pike, Bethesda, 
    MD.
    
    Contact: Paul W. Goebel, Office of Health Affairs (HFY-20), Food and 
    Drug Administration, rm. 15-22, 5600 Fishers Lane, Rockville, MD 20857, 
    301-827-1685, FAX 301-443-0232, or e-mail pgoebel@oc.fda.gov''.
    
    Registration: Pre-registration is not required; however, for conference 
    planning purposes, those who plan to attend are requested to fax or e-
    mail their registration information (including name, firm name, 
    address, phone, fax number, and e-mail) to Glen Drew, FAX 301-443-0232, 
    e-mail gdrew@oc.fda.gov'' or call Paul Goebel, Paula Waterman, or 
    Glen Drew at 301-827-1685. There is no fee for attending the 
    conference, and it is open to all. The agenda and background material 
    are available on FDA's internet site at ``http://www.fda.gov/oc/oha/
    irbagenda.htm''.
         If you need special accommodations due to a disability, please 
    contact Paul Goebel at least 7 days in advance.
    
        Dated: February 10, 1999.
     William K. Hubbard,
     Associate Commissioner for Policy Coordination.
    [FR Doc. 99-3775 Filed 2-16-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
02/17/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of meeting.
Document Number:
99-3775
Pages:
7896-7896 (1 pages)
PDF File:
99-3775.pdf